» Articles » PMID: 36428785

Non-Coding RNAs of Extracellular Vesicles: Key Players in Organ-Specific Metastasis and Clinical Implications

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Nov 26
PMID 36428785
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) are heterogeneous membrane-encapsulated vesicles released by most cells. They act as multifunctional regulators of intercellular communication by delivering bioactive molecules, including non-coding RNAs (ncRNAs). Metastasis is a major cause of cancer-related death. Most cancer cells disseminate and colonize a specific target organ via EVs, a process known as "organ-specific metastasis". Mounting evidence has shown that EVs are enriched with ncRNAs, and various EV-ncRNAs derived from tumor cells influence organ-specific metastasis via different mechanisms. Due to the tissue-specific expression of EV-ncRNAs, they could be used as potential biomarkers and therapeutic targets for the treatment of tumor metastasis in various types of cancer. In this review, we have discussed the underlying mechanisms of EV-delivered ncRNAs in the most common organ-specific metastases of liver, bone, lung, brain, and lymph nodes. Moreover, we summarize the potential clinical applications of EV-ncRNAs in organ-specific metastasis to fill the gap between benches and bedsides.

Citing Articles

Role of Triple-Negative Breast Cancer-Derived Extracellular Vesicles in Metastasis: Implications for Therapeutics and Biomarker Development.

Wan X, Yang L, Wu L, Lei J, Li J J Cell Mol Med. 2025; 29(5):e70448.

PMID: 40032646 PMC: 11875785. DOI: 10.1111/jcmm.70448.


Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.

Bar O, Porgador A, Cooks T J Extracell Biol. 2024; 3(9):e70011.

PMID: 39328262 PMC: 11424882. DOI: 10.1002/jex2.70011.


Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma.

Yuan Y, Wu D, Li J, Huang D, Zhao Y, Gao T Front Pharmacol. 2023; 14:1217400.

PMID: 37663266 PMC: 10470150. DOI: 10.3389/fphar.2023.1217400.


Non-Coding RNAs Derived from Extracellular Vesicles Promote Pre-Metastatic Niche Formation and Tumor Distant Metastasis.

Cheng J, Zhang K, Qu C, Peng J, Yang L Cancers (Basel). 2023; 15(7).

PMID: 37046819 PMC: 10093357. DOI: 10.3390/cancers15072158.


Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules.

Alotaibi F Front Genet. 2023; 14:1052731.

PMID: 36873941 PMC: 9982116. DOI: 10.3389/fgene.2023.1052731.

References
1.
Li Z, Yu C, Zhong Y, Liu T, Huang Q, Zhao X . Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann Oncol. 2011; 23(3):638-646. DOI: 10.1093/annonc/mdr290. View

2.
Wang M, Zhou L, Yu F, Zhang Y, Li P, Wang K . The functional roles of exosomal long non-coding RNAs in cancer. Cell Mol Life Sci. 2019; 76(11):2059-2076. PMC: 11105177. DOI: 10.1007/s00018-019-03018-3. View

3.
Lang C, Dai Y, Wu Z, Yang Q, He S, Zhang X . SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis. Mol Oncol. 2020; 14(4):808-828. PMC: 7138406. DOI: 10.1002/1878-0261.12634. View

4.
Jiang K, Li G, Chen W, Song L, Wei T, Li Z . Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas. Onco Targets Ther. 2020; 13:1311-1319. PMC: 7025673. DOI: 10.2147/OTT.S231361. View

5.
Wang D, Zhang W, Zhang C, Wang L, Chen H, Xu J . Exosomal non-coding RNAs have a significant effect on tumor metastasis. Mol Ther Nucleic Acids. 2022; 29:16-35. PMC: 9207556. DOI: 10.1016/j.omtn.2022.05.034. View